Ventyx Biosciences, Inc. — Investor Relations & Filings
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company that develops innovative oral therapies for autoimmune, inflammatory, and neurodegenerative diseases. The company utilizes its expertise in medicinal chemistry, structural biology, and immunology to discover and advance differentiated small molecule therapeutics for conditions with high unmet medical needs. Its clinical pipeline features a portfolio of NLRP3 inhibitors, including VTX2735, a peripherally restricted candidate in Phase 2 development for recurrent pericarditis, and VTX3232, a CNS-penetrant candidate in Phase 2 for neurodegenerative and cardiometabolic diseases. Additionally, its inflammatory bowel disease portfolio includes tamuzimod, an S1P1R modulator, and VTX958, a TYK2 inhibitor, both of which have completed Phase 2 clinical trials.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-01-07 | English | |
| 4 | 2025-12-19 | English | |
| 4 | 2025-12-19 | English | |
| Regulatory Filings 2025 | 2025-12-19 | English | |
| Regulatory Filings 2025 | 2025-12-19 | English | |
| Major Shareholding Notification 2025 | 2025-11-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 13409141 | 8-K | 2026-01-07 | English | ||
|
2025
14 filings
| |||||
| 13409144 | 4 | 2025-12-19 | English | ||
| 13409148 | 4 | 2025-12-19 | English | ||
| 13409150 | Regulatory Filings 2025 | 2025-12-19 | English | ||
| 13409153 | Regulatory Filings 2025 | 2025-12-19 | English | ||
| 13409157 | Major Shareholding Notification 2025 | 2025-11-27 | English | ||
| 13409161 | 4 | 2025-11-19 | English | ||
| 13409164 | 4 | 2025-11-19 | English | ||
| 13409215 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13409213 | 10-Q | 2025-11-06 | English | ||
| 13409224 | 8-K | 2025-11-06 | English | ||
| 13409228 | Major Shareholding Notification 2025 | 2025-10-31 | English | ||
| 13409270 | 8-K | 2025-10-22 | English | ||
| 13409272 | Major Shareholding Notification 2025 | 2025-08-14 | English | ||
| 13409302 | 10-Q | 2025-08-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Ventyx Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ventyx Biosciences, Inc. (id: 33798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.